$ATRA Atara Biotherapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Atara Biotherapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Atara Biotherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Atara Biotherapeutics, Inc. for free.

CIK Number: 0001604464
IRS Number: 460920988
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ATRA
Company Address: 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO 94080

Atara Biotherapeutics, Inc. operates as a clinical stage company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.

Market Capitalization: $434.34M
Prev close: $15.05
Average Daily Volume: 231,402
Days Low: $14.70
Year Low: $12.45
Year High: $25.73

Atara Biotherapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Ciechanover Isaac E.Chief Executive Officer272,8784,106,814shares bought: 591,354 / shares sold: -748,957 SELLFeb 14 20185 days ago
Clark Mitchall G.EVP & Chief R & QA Officer179,9132,707,691shares bought: 124,981 / shares sold: -28,532 STRONG BUYFeb 12 20187 days ago
Haqq ChristopherEVP, R&D & Chief Scientific Of350,6795,277,719shares bought: 162,804 / shares sold: -107,365 BUYFeb 12 20187 days ago
MCGRATH JOHNEVP & Chief Financial Officer105,5561,588,618shares bought: 170,535 / shares sold: -116,693 BUYFeb 12 20187 days ago
Newell JoeChief Tech. Operations Officer32,500489,125shares bought: 32,500 / shares sold: 0 STRONG BUYFeb 08 201811 days ago
Porter DerrellSVP, Head of Global Commercial14,044211,362shares bought: 12,500 / shares sold: 0 BUYFeb 08 201811 days ago
Sofer GadEVP & Chief Strategy Officer265,5803,996,979shares bought: 215,836 / shares sold: -76,648 STRONG BUYFeb 12 20187 days ago
Turner Heather DFormer EVP, GC & Sec.77,1121,160,536shares bought: 49,500 / shares sold: -16,648 BUYFeb 12 20187 days ago

View all Atara Biotherapeutics, Inc. insiders.

Atara Biotherapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 14 2018ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS49.253,100152,675262,878266 K to 262.9 K (-1.17 %)
Feb 14 2018ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS48.425,800280,836265,978271.8 K to 266 K (-2.13 %)
Feb 14 2018ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS46.941,00046,940271,778272.8 K to 271.8 K (-0.37 %)
Feb 14 2018ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS45.051004,505272,778272.9 K to 272.8 K (-0.04 %)
Feb 14 2018ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS45.1010,000451,000272,878282.9 K to 272.9 K (-3.54 %)
Feb 12 2018ATRAAtara Biotherapeut ...Turner Heather DFormer EVP, GC & Se ...SellS41.691,56265,12069,49471.1 K to 69.5 K (-2.20 %)
Feb 12 2018ATRAAtara Biotherapeut ...Turner Heather DFormer EVP, GC & Se ...SellS40.6260024,37271,05671.7 K to 71.1 K (-0.84 %)
Feb 12 2018ATRAAtara Biotherapeut ...Turner Heather DFormer EVP, GC & Se ...SellS39.6673329,07171,65672.4 K to 71.7 K (-1.01 %)
Feb 12 2018ATRAAtara Biotherapeut ...Turner Heather DFormer EVP, GC & Se ...SellS38.6360023,17872,38973 K to 72.4 K (-0.82 %)
Feb 12 2018ATRAAtara Biotherapeut ...Turner Heather DFormer EVP, GC & Se ...SellS37.384,123154,11872,98977.1 K to 73 K (-5.35 %)
Feb 12 2018ATRAAtara Biotherapeut ...Turner Heather DFormer EVP, GC & Se ...SellS36.634,596168,35177,11281.7 K to 77.1 K (-5.62 %)
Feb 12 2018ATRAAtara Biotherapeut ...Clark Mitchall G.EVP & Chief R & QA ...Payment of ExerciseF41.703,704154,457179,913183.6 K to 179.9 K (-2.02 %)
Feb 12 2018ATRAAtara Biotherapeut ...Haqq ChristopherEVP, R&D & Chief Sc ...Payment of ExerciseF41.704,925205,373350,679355.6 K to 350.7 K (-1.38 %)
Feb 12 2018ATRAAtara Biotherapeut ...Soffer GadEVP & Chief Strateg ...Payment of ExerciseF41.704,169173,847265,580269.7 K to 265.6 K (-1.55 %)
Feb 12 2018ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...Payment of ExerciseF41.704,819200,952105,556110.4 K to 105.6 K (-4.37 %)

View all Atara Biotherapeutics, Inc. insider transactions.